Recon: FDA approves Lilly’s Alzheimer’s drug Kisunla; Biden calls on Novo, Lilly to reduce weight-loss drug prices
ReconMichael Mezher
Approval/marketing authorizationBiologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicySubmission and registrationUnited States